The lung cancer program features faculty-led discussions on the data, therapies, and clinical challenges shaping thoracic oncology today. From targeted therapy to immunotherapy, sessions offer real-world insight into how new research is changing treatment decisions in practice. Explore the highlights and meet the experts guiding the conversation.

Agenda Highlights

March 14, 10:25 AM
First-Line Strategies in EGFR-Mutated Metastatic NSCLC: Monotherapy Approaches vs Combination Approaches
March 14, 4:25 PM
Resectable Lung Cancer: Neoadjuvant Only vs Perioperative Therapy
March 15, 10:25 AM
Management of Oligo-Remnant Metastatic Lung Cancer: Systemic Therapy Alone vs Systemic Therapy Plus Local Ablation
Back to top